Hirschman Shalom 4

What Happened
Shalom Hirschman, a director of Klotho Neurosciences, received an award/grant of 350,000 shares on March 4, 2026. The Form 4 lists this as an "A" (award/grant) transaction; no per-share price or total dollar value is reported (price = N/A). An award is compensation rather than an open‑market purchase or sale and does not itself indicate a buying or selling market signal.

Key Details

• Transaction date: 2026-03-04 (reported on Form 4 filed 2026-03-06). Filing appears timely under the two-business-day rule.
• Transaction type/code: A — grant/award under the company’s Equity Incentive Plan.
• Shares granted: 350,000. Price/total value: not disclosed (N/A).
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: F1 — shares were received as a grant under the company’s Equity Incentive Plan.

Context
Equity grants are typically part of director or employee compensation and often vest over time or subject to other conditions; they are different from outright purchases or sales. For retail investors, purchases can be a stronger signal of insider conviction than awards, which primarily reflect compensation policy. This filing does not show an exercise, sale, or gift—just an issuance of shares to a director.